1/28
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Objectives
Discuss Barbiturates
Discuss other hypnotic and anxiolytic agents
Mechanism of Action
Bind to GABAA receptors, enhances GABAergic transmission
Prolonging the duration of the chloride channel opening
Blocks excitatory glutamate receptors
Compare and contrast benzos and barbiturates
GABA enhancing action of barbiturate is greater than that of the benzodiazepines
Enhances the efficacy of GABA by increasing the time that the cl- channel stays open
What is the therapeutic action of barbiturates? When would benzos be used?
Barbiturates have been largely replaced by benzodiazepines in most clinical applications
Benzodiazepines are safer, cause less tolerance, fewer withdrawal symptoms and induce fewer profound effects on drug metabolizing enzymes
Used in general anesthesia
As antiepileptic agents, and for neuroprotection
Adverse effects of barbiturates with other substances
Concomitant administration of barbiturate and other CNS depressants
Administration with ethanol results in CNS depression more severe than that caused by barbiturates alone
Adverse effects of barbiturates
Metabolism of barbiturates
Barbiturates induce cytochrome P450 (CYP450) microsomal enzymes in the liver
Chronic barbiturate administration diminishes the action of many drugs that are metabolized by the CYP450 system
What is first line treatment for general anxiety disorder?
Antidepressants
Efficacy in managing the symptoms of chronic anxiety disorders
SSRIs and SNRIs, used alone or in combination with low dose of benzodiazepine
Which SSRIs and SNRIs are used for anxiety?
SSRIs: Escitalopram, Citalopram, Fluoxetine, Fluvoxamine, Sertraline
SNRIs: Venlafaxine, Duloxetine
What is the treatment guideline for persistent anxiety?

What are non-benzodiazepine hypnotic agents?

Zolpidem
What does it act on?
Describe the onset of action
Acts on a subset of the benzodiazepine receptor family (GABA)
Rapid onset of action, effect for approximately 5 hours
What are ADE of zolpidem?
nightmares
agitation
headache
GI upset
Prolonged use
little tolerance occurs
few withdrawal side effect
Zaleplon
Compare to zolpidem and benzodiazepines
Who cannot use them?
Fewer residual effect on psychomotor and cognitive functions compared to zolpidem or benzodiazepines
(due to rapid elimination with a half life of approximately 1 hour)
Not recommended to use during pregnancy and while breast feeding
Eszopiclone
MOA
Indication
ADE
Bind to GABA receptor
Used for treating insomnia
Half life is approximately 7 hours
Adverse effect
Higher dose: cause CNS depression
Dose adjustment - concomitant with CNS depressants
Long-term use of medications in this class is not recommended during pregnancy
Buspirone MOA
5HT1A agonist
Increases serotonin receptor action
Blocks presynaptic dopamine D2 receptors
(enhanced dopamine neurotransmission)
Buspirone ADE and Disadvantage
Frequency of adverse effect is low,
Most common adverse effect
headache, dizziness, nervousness and lightheadedness, and restlessness
Disadvantage: slow onset of action
(takes days or weeks to produce effect)
Ramelteon
MOA
Therapeutic Action
ADE
Selective agonist at the MT1 and MT2
subtypes of melatonin receptors
No evidence of dependence or withdrawal effects
ADE: dizziness, fatigue, and somnolence
What drugs are in the Orexin receptor antagonists class?
Suvorexant (Belsomra)
Lemborexant (Dayvigo)
Daridorexant (Quviviq)
Orexin
What is it and what is it involved in?
What is the MOA?
How are they mediated?
1.Orexin (hypocretin) is a neuropeptide
Regulates arousal, wakefulness and appetite
2.Orexin producing neurons
Project from the lateral hypothalamus to neurons and brain regions that modulate wakefulness
3.Orexins are mediated via two types of G-Protein coupled receptors (GPCRs), orexin 1 receptor (OX1R) and orexin 2 receptor (OX2R)
Activated OX2Rs โ Depolarize orexin neurons โ Increase presynaptic glutamate release (No GABA regulation)
Orexin receptor antagonists MOA
Inhibit OX2Rs โ Decrease presynaptic glutamate release
What is the action, advantage and ADE of Orexin receptor antagonists?
Action: Inducing sleep by inhibiting the excitatory neurotransmission, mediated through orexin
Advantage: target a more localized area of the brain
Adverse effects: next day drowsiness, cause dependence
Which drugs in these classes are involved in sleep?
TCAs
Amitriptyline (Elavil)
Doxepin (Sinequan)
Atypical Antidepressants
Trazodone (Desyrel) - very effective in treating sleep disturbance in Alzheimerโs disease
Mirtazapine (Remeron) - positive impact on insomnia symptoms in people with clinical depression
Antihistamines
Diphenhydramines (Benadryl)
Hydroxyzine (vistaril, Atarax)
Doxylamine (Diclegis)
To treat mild types of insomnia, over the counter hypnotic agents
Ethanol
MOA
Action
ADE
Increases GABA receptor mediated synaptic inhibition AND Inhibits the NMDA glutamate receptor
CNS depressant, anxiolytic and sedative effects
Liver disease, gastritis, nutritional deficiencies, cardiomyopathy
Synergize with many other sedative agents and can cause severe CNS depression when used in conjunction with benzodiazepine, antihistamines, and barbiturates
Classification of Anxiolytic Drugs
Benzodiazepines
5-HT1AReceptor Agonist
Serotonin Reuptake Inhibitors (SSRIs)
Benzodiazepines
Alprazolam
Chlordiazepoxide
Diazepam
Lorazepam
Oxazepam
Midazolam
5-HT1AReceptor Agonist โ Buspirone
Serotonin Reuptake Inhibitors (SSRIs)
Citalopram
Escitalopram
Fluoxetine
Fluvoxamine
Paroxetine
Sertraline
Drugs to treat Insomnia
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Benzodiazepines
Estrazolam
Flurazepam
Quazepam
Temazepam
Triazolam
Nonbenzodiazepines
Zaleplon
Zolpidem
Eszopiclone
Ramelteon
Suvorexant
Lemborexant
Daridorexant
Antidepressants
Amitriptyline
Doxepin
Trazodone
Mirtazapine
Which non-benzodiazepin drug is known for its minical muscle relaxant and
A.
B.
djf
Which non-benzodiazepine drug is often prescribed for
fj
What is the primary medical application of orexin receptor antagonists?
A.
B.
C.
D.
nn